| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |